InsiderClue
Stocks · Health care · Pharmaceutical Preparations

CYTOKINETICS INC

CYTK Clue Score32
United States Fiscal year ends December CIK 0001061983 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

19
Insider
Date
Role
Action
Shares
Price
Amount
Robert I Blum
17 Mar 2026
President & CEO
Sell
23,928
$62.15
$1.49M
Robert I Blum
17 Mar 2026
President & CEO
Sell
12,673
$62.15
$787.63K
Fady Ibraham Malik
17 Mar 2026
EVP Research & Development
Sell
4,397
$62.15
$273.27K
Fady Ibraham Malik
17 Mar 2026
EVP Research & Development
Sell
7,636
$62.15
$474.58K
Andrew Callos
17 Mar 2026
EVP, Chief Commercial Officer
Sell
2,916
$62.15
$181.23K
Andrew Callos
17 Mar 2026
EVP, Chief Commercial Officer
Sell
5,626
$62.15
$349.66K
Sung Lee
17 Mar 2026
EVP, Chief Financial Officer
Sell
4,935
$62.15
$306.71K
Robert I Blum
9 Mar 2026
President & CEO
Sell
7,931
$60.72
$481.57K
Fady Ibraham Malik
9 Mar 2026
EVP Research & Development
Sell
2,907
$60.72
$176.51K
Andrew Callos
9 Mar 2026
EVP, Chief Commercial Officer
Sell
2,582
$60.72
$156.78K
Robert I Blum
17 Mar 2025
President & CEO
Sell
12,648
$44.38
$561.32K
Fady Ibraham Malik
17 Mar 2025
EVP Research & Development
Sell
4,389
$44.38
$194.78K
Andrew Callos
17 Mar 2025
EVP, Chief Commercial Officer
Sell
2,775
$44.38
$123.15K
Robert I Blum
6 Mar 2025
President & CEO
Sell
16,970
$43.44
$737.18K
Fady Ibraham Malik
6 Mar 2025
EVP Research & Development
Sell
8,228
$43.27
$356.03K
Andrew Callos
6 Mar 2025
EVP, Chief Commercial Officer
Sell
3,341
$43.27
$144.57K
Robert I Blum
3 Mar 2025
President & CEO
Sell
8,743
$42.88
$374.90K
Andrew Callos
3 Mar 2025
EVP, Chief Commercial Officer
Sell
1,114
$42.88
$47.77K
Fady Ibraham Malik
3 Mar 2025
EVP Research & Development
Sell
2,449
$42.88
$105.01K
Showing 250 of 713 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 856
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 71
Sales straight out of an exercise 469
Sales at will 156
Transactions with no price 0
Shares from compensation/vesting 6,847,448
Sales filed before the plan box existed 137
History held since 3 Oct 2006